JPRN-UMIN000032254尚未招募2 期
PhaseIII trial of neoadjuvant chemotherapy using CAPEOX with optional local treatment for locally advanced rectal cancer - NEXT trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 440
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous (within 5 years)malignancies other than carcinoma in situ or mucosal carcinoma 2) Bowel obstruction 3) Uncontrollable diabetes mellitus (HbA1c>=8.0) 4) Unstable ungina pectoris 5) Liver cirrhosis,Liver failure 6) Interstitial pneumonia 7) Pregnant or possibly pregnant women 8) Past history of using 5-FU, oxaliplatin based chemotherapy 9) Past history of radiotherapy 10) Other conditions judged ineligible by physician
研究者
相似试验
招募中
2 期
Phase II study of neo-adjuvant chemotherapy with combination therapy of gemcitabine and S-1 in patients with resectable pancreatic cancerresectable pancreatic cancerJPRN-UMIN000005912Tokai university, school of medicine50
已完成
2 期
Phase II study of neoadjuvant chemotherapy with CPT-11 and S-1 for locally advanced colorectal cancer with lymph node metastases.locally advanced colorectal cancer with lymph node metastasesJPRN-UMIN000001698iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35
已完成
不适用
PhaseII study of neoadjuvant chemotherapy with the nab Paclitaxel And Trastuzumab followed by FEC for the HER2-positive resectable primary breast cancerHER2 positive resectable primary breast cancerJPRN-UMIN000008465Osaka Breast Cancer Chemo-Endocrine Therapy Study Group30
招募中
2 期
A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.Biliary tract cancer (Intrahepatic cholangiocarcinoma, Extrahepatic cholangiocarcinoma, Gallbladder carcinoma)JPRN-UMIN000015330Adjuvant therapy for BTC Research Group50
已完成
1 期
Phase I/II trial of neoadjuvant chemotherapy with cisplatin and weekly paclitaxel in patients with stage Ib2- IIb uterine cervical cancerpatients with clinical stage Ib2, IIa(primary tumor diameter4 or more cm),IIb uterine cervical cancerJPRN-UMIN000002636Hyogo Cancer Center40